Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Véronique Hefter"'
Autor:
Christian Keller, Christian Bauer, Elisabeth Mack, Véronique Hefter, Alexandra Fischer, Kirsten Volland, Chrysanthi Skevaki, Andreas Neubauer, Thomas Gress, Stephan Becker
Objectives: Circulating nucleocapsid (NCP) antigen of SARS-CoV-2 is increased in severely ill COVID-19 patients. However, clinical deterioration of COVID-19 often happens about one week after benign initial presentation. The role of NCP antigenemia a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::294467ca2f151f731751f5e7ebcf2405
https://doi.org/10.22541/au.167958004.48819805/v1
https://doi.org/10.22541/au.167958004.48819805/v1
Autor:
Addi J. Romero-Olmedo, Axel Ronald Schulz, Svenja Hochstätter, Dennis Das Gupta, Heike Hirseland, Daniel Staudenraus, Bärbel Camara, Kirsten Volland, Véronique Hefter, Siddhesh Sapre, Verena Krähling, Helena Müller-Kräuter, Henrik E. Mei, Christian Keller, Michael Lohoff
A third mRNA-based “booster” vaccination is the favored strategy to maintain protection against SARS-CoV-2 infection. Yet, significant waning of specific immunity within six months after 2nd vaccination, along with higher incidence of breakthroug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d8160cd519cec4fc425887a79c9d7b0
https://doi.org/10.1101/2022.02.10.22270733
https://doi.org/10.1101/2022.02.10.22270733
Autor:
Addi J, Romero-Olmedo, Axel Ronald, Schulz, Svenja, Hochstätter, Dennis Das, Gupta, Heike, Hirseland, Daniel, Staudenraus, Bärbel, Camara, Kirsten, Volland, Véronique, Hefter, Siddhesh, Sapre, Verena, Krähling, Helena, Müller-Kräuter, Ho-Ryun, Chung, Henrik E, Mei, Christian, Keller, Michael, Lohoff
Publikováno v:
The Lancet Infectious Diseases. 22:588-589
Autor:
Daniel Staudenraus, Siddhesh Sapre, Iiris Virta, Heike Hirseland, Dennis DasGupta, Axel Schulz, Addi Romero Olmedo, Carina Münch, Svenja Hochstäter, Christian Keller, Bärbel Camara, Michael Lohoff, Henrik E. Mei, Véronique Hefter
Herein, we compared SARS-CoV-2-specific antibody and T-cell responses to two doses of BNT162b2 mRNA in 51 vaccinees > 80 years old and 46 (20–53 years old) controls. The responses of the elderly were much lower and 10% non-responders were identifie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea26beed0e6f28a9e4efcc7dca41e0b5
https://doi.org/10.21203/rs.3.rs-900790/v1
https://doi.org/10.21203/rs.3.rs-900790/v1
Autor:
Addi J. Romero-Olmedo, Axel Ronald Schulz, Svenja Hochstätter, Dennis Das Gupta, Iiris Virta, Heike Hirseland, Daniel Staudenraus, Bärbel Camara, Carina Münch, Véronique Hefter, Siddhesh Sapre, Verena Krähling, Helena Müller-Kräuter, Marek Widera, Henrik E. Mei, Christian Keller, Michael Lohoff
Publikováno v:
Nature microbiology
Here we compared SARS-CoV-2-specific antibody and T-cell responses between older adults (80 years old, n = 51) and a younger control group (20-53 years old, n = 46) after receiving two doses of BNT162b2. We found that responses in older adults were g